Next earnings date: 12 Aug 2025
NeuroOne Medical Technologies Corporation – NASDAQ:NMTC
NeuroOne Medical Technologies stock price today
$0.788
-0.03
-3.69%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
NeuroOne Medical Technologies stock price monthly change
-13.89%
month
NeuroOne Medical Technologies stock price quarterly change
-13.89%
quarter
NeuroOne Medical Technologies stock price yearly change
-47.56%
year
NeuroOne Medical Technologies key metrics
Market Cap | 22.85M |
Enterprise value | 24.45M |
P/E | -3.25 |
EV/Sales | 356.36 |
EV/EBITDA | -2.77 |
Price/Sales | 422.13 |
Price/Book | 3.54 |
PEG ratio | -0.10 |
EPS | -0.65 |
Revenue | 3.21M |
EBITDA | -12.83M |
Income | -12.98M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -13003.81% |
Oper. margin | -13121.66% |
Gross margin | -518.34% |
EBIT margin | -13121.66% |
EBITDA margin | -399.13% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNeuroOne Medical Technologies stock price history
NeuroOne Medical Technologies stock forecast
NeuroOne Medical Technologies financial statements
| Mar 2023 | 466.17K | -3.52M | -755.69% |
|---|---|---|---|
| Jun 2023 | 629.90K | -3.46M | -550.68% |
| Sep 2023 | 741.78K | -3.13M | -422.65% |
| Mar 2024 | 1.37M | -2.85M | -207.3% |
| Sep 2025 | 3M | -1.43M | -47.99% |
|---|---|---|---|
| Oct 2025 | 3M | -1.55M | -51.82% |
| Dec 2025 | 3.3M | -906.05K | -27.46% |
| Dec 2025 | 3.3M | -1.29M | -39.26% |
Analysts Price target
Financials & Ratios estimates
| Mar 2023 | 7205106 | 1.67M | 23.21% |
|---|---|---|---|
| Jun 2023 | 5758124 | 1.83M | 31.9% |
| Sep 2023 | 8097314 | 1.84M | 22.82% |
| Mar 2024 | 5394902 | 1.54M | 28.55% |
| Mar 2023 | -3.55M | 1.82M | 661.96K |
|---|---|---|---|
| Jun 2023 | -2.94M | 860.70K | 1.56M |
| Sep 2023 | -2.90M | -50.12K | 5.19M |
| Mar 2024 | -2.17M | -31.36K | 1.96M |
NeuroOne Medical Technologies alternative data
| Aug 2023 | 15 |
|---|---|
| Sep 2023 | 15 |
| Oct 2023 | 15 |
| Nov 2023 | 15 |
| Dec 2023 | 15 |
| Jan 2024 | 16 |
| Feb 2024 | 16 |
| Mar 2024 | 16 |
| Apr 2024 | 16 |
| May 2024 | 16 |
| Jun 2024 | 16 |
| Jul 2024 | 16 |
NeuroOne Medical Technologies other data
5.53%
-2.42%
of NMTC is owned by hedge funds
897.97K
-374.78K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Sep 2023 | 50900 | 0 |
| Jun 2024 | 0 | 27989 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | CHRISTIANSON MARK officer: Business Development D.. | Common Stock | 2,189 | $0.88 | $1,918 | ||
Sale | CHRISTIANSON MARK officer: Business Development D.. | Common Stock | 25,800 | $0.88 | $22,652 | ||
Purchase | MCCLURG RONALD W. officer: Chief Fi.. | Common Stock | 50,900 | $0.98 | $50,035 | ||
Sale | CHRISTIANSON MARK officer: Business Development D.. | Common Stock | 12,711 | $1.5 | $19,092 | ||
Sale | CHRISTIANSON MARK officer: Business Development D.. | Common Stock | 11,667 | $1.51 | $17,606 | ||
Sale | CHRISTIANSON MARK officer: Business Development D.. | Common Stock | 2,122 | $1.61 | $3,406 | ||
Purchase | MCCLURG RONALD W. officer: Chief Fi.. | Common Stock | 10,000 | $1.02 | $10,220 | ||
Purchase | MCCLURG RONALD W. officer: Chief Fi.. | Common Stock | 14,000 | $1.06 | $14,784 | ||
Purchase | MCCLURG RONALD W. officer: Chief Fi.. | Common Stock | 10,500 | $0.98 | $10,290 | ||
Purchase | MCCLURG RONALD W. officer: Chief Fi.. | Common Stock | 17,500 | $0.85 | $14,928 |
| Quarter | Transcript |
|---|---|
| Q2 2024 14 May 2024 | Q2 2024 Earnings Call Transcript |
| Q1 2024 13 Feb 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 14 Dec 2023 | Q4 2023 Earnings Call Transcript |
| Q3 2023 14 Aug 2023 | Q3 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. David A. Rosa M.D. (1964) Pres, Chief Executive Officer & Director | $603,450 |
Mr. Steven Mertens (1962) Chief Technology Officer | $298,970 |
| Mr. Ronald W. McClurg (1959) Chief Financial Officer | $294,470 |
-
What's the price of NeuroOne Medical Technologies stock today?
One share of NeuroOne Medical Technologies stock can currently be purchased for approximately $0.79.
-
When is NeuroOne Medical Technologies's next earnings date?
NeuroOne Medical Technologies Corporation is estimated to report earnings on Tuesday, 12 Aug 2025.
-
Does NeuroOne Medical Technologies pay dividends?
No, NeuroOne Medical Technologies does not pay dividends.
-
How much money does NeuroOne Medical Technologies make?
NeuroOne Medical Technologies has a market capitalization of 22.85M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 76.86% to 3.45M US dollars.
-
What is NeuroOne Medical Technologies's stock symbol?
NeuroOne Medical Technologies Corporation is traded on the NASDAQ under the ticker symbol "NMTC".
-
What is NeuroOne Medical Technologies's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of NeuroOne Medical Technologies?
Shares of NeuroOne Medical Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are NeuroOne Medical Technologies's key executives?
NeuroOne Medical Technologies's management team includes the following people:
- Mr. David A. Rosa M.D. Pres, Chief Executive Officer & Director(age: 61, pay: $603,450)
- Mr. Steven Mertens Chief Technology Officer(age: 63, pay: $298,970)
- Mr. Ronald W. McClurg Chief Financial Officer(age: 66, pay: $294,470)
-
How many employees does NeuroOne Medical Technologies have?
As Jul 2024, NeuroOne Medical Technologies employs 16 workers.
-
When NeuroOne Medical Technologies went public?
NeuroOne Medical Technologies Corporation is publicly traded company for more then 7 years since IPO on 15 Mar 2018.
-
What is NeuroOne Medical Technologies's official website?
The official website for NeuroOne Medical Technologies is n1mtc.com.
-
Where are NeuroOne Medical Technologies's headquarters?
NeuroOne Medical Technologies is headquartered at 7599 Anagram Drive, Eden Prairie, MN.
-
How can i contact NeuroOne Medical Technologies?
NeuroOne Medical Technologies's mailing address is 7599 Anagram Drive, Eden Prairie, MN and company can be reached via phone at +95 2 426 1383.
NeuroOne Medical Technologies company profile:
NeuroOne Medical Technologies Corporation
n1mtc.comExchange:
NASDAQ
Full time employees:
16
Industry:
Medical - Devices
Sector:
Healthcare
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
7599 Anagram Drive
Eden Prairie, MN 55344
Eden Prairie, MN 55344
CIK: 0001500198
ISIN: US64130M2098
CUSIP: 64130M209
